Spironolactone and congestive heart-failure
- 1 April 2000
- journal article
- Published by Elsevier in The Lancet
- Vol. 355 (9212) , 1369-1370
- https://doi.org/10.1016/s0140-6736(05)72606-4
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Early uptake of research findings after fast-track publicationThe Lancet, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Effectiveness of Spironolactone Added to an Angiotensin-Converting Enzyme Inhibitor and a Loop Diuretic for Severe Chronic Congestive Heart Failure (The Randomized Aldactone Evaluation Study [RALES])**See Appendix for full list of RALES investigators.The American Journal of Cardiology, 1996
- ACE inhibitor co-therapy in patients with heart failure: Rationale for the Randomized Aldactone Evaluation Study (RALES)European Heart Journal, 1995